Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Aging01:26

Aging

92
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
92
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
What is Cancer?02:12

What is Cancer?

10.9K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

405
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
405
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Perceptions of Medicare Annual Wellness Visits: Findings From a Pilot Survey.

Journal of the American Geriatrics Society·2026
Same author

Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay.

JAMA cardiology·2026
Same author

Key components of effective contact interventions for reducing public mental health stigma: An updated meta-analysis.

Clinical psychology review·2026
Same author

Evaluation of the Distress Thermometer in older patients with cancer.

Journal of geriatric oncology·2025
Same author

Joint British Societies' position statement on cardiology training in the United Kingdom.

Heart (British Cardiac Society)·2024
Same author

Amoebic encephalitis within Australia.

Internal medicine journal·2024
Same journal

Evolving Therapeutic Strategies in Neuroendocrine Neoplasms: A New Era of Personalized Therapies.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same journal

Multiple Chapters, One Career: Using Career Development Plans to Find Success and Satisfaction in Academic Oncology Across the Career Spectrum.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same journal

Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same journal

Optimal Use of Targeted Therapy and Immunotherapy in Early-Stage, Resectable Non-Small Cell Lung Cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same journal

Before the Race Even Starts: Early Intervention to Prevent Long-Term Late Effects From Childhood Cancer Therapies.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same journal

Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
See all related articles

Related Experiment Video

Updated: Jul 31, 2025

Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

17.0K

Developing Sustainable Cancer and Aging Programs.

Tina Hsu1, Rawad Elias2,3, Kristine Swartz4

  • 1The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|May 8, 2023
PubMed
Summary
This summary is machine-generated.

Geriatric assessment (GA) improves cancer treatment outcomes for older adults by reducing toxicity and hospitalizations. This approach is adaptable to various healthcare settings, addressing low GA uptake.

More Related Videos

Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

33.6K
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.1K

Related Experiment Videos

Last Updated: Jul 31, 2025

Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

17.0K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

33.6K
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.1K

Area of Science:

  • Geriatric Oncology
  • Cancer Care in Older Adults

Background:

  • Geriatric assessment (GA) is proven to reduce cancer treatment toxicity and hospitalizations in older adults.
  • The aging cancer population necessitates effective strategies for managing age-related complexities in cancer care.
  • Despite recommendations from major oncology societies, the adoption of GA remains low due to perceived barriers like lack of knowledge, time, and resources.

Purpose of the Study:

  • To provide a practical and sustainable framework for developing, implementing, and maintaining geriatric oncology programs.
  • To address the challenges hindering the widespread adoption of geriatric assessment in cancer care.
  • To offer an adaptable approach for integrating GA into diverse healthcare contexts.

Main Methods:

  • The study outlines a systematic approach for program development and implementation.
  • It emphasizes adaptability across different healthcare settings, from low-resource to high-resource environments.
  • Strategies for overcoming common barriers to GA uptake are discussed.

Main Results:

  • GA effectively enhances treatment completion and reduces adverse events in elderly cancer patients.
  • The proposed framework is designed for sustainability and feasibility in clinical practice.
  • The approach is versatile, catering to both established and emerging geriatric oncology fields.

Conclusions:

  • Implementing geriatric assessment programs is crucial for optimizing cancer care in the growing older adult population.
  • The presented approach facilitates the development and sustainment of geriatric oncology initiatives.
  • Overcoming barriers to GA adoption can significantly improve patient outcomes and healthcare efficiency.